Compare BDSX & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | CTW |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Precision Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 125.4M |
| IPO Year | 2020 | N/A |
| Metric | BDSX | CTW |
|---|---|---|
| Price | $14.29 | $2.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.50 | N/A |
| AVG Volume (30 Days) | ★ 129.7K | 30.5K |
| Earning Date | 05-12-2026 | 05-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,499,000.00 | N/A |
| Revenue This Year | $25.26 | N/A |
| Revenue Next Year | $19.70 | N/A |
| P/E Ratio | ★ N/A | $22.41 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.25 | $1.10 |
| 52 Week High | $20.21 | $3.14 |
| Indicator | BDSX | CTW |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 66.03 |
| Support Level | $6.33 | $1.85 |
| Resistance Level | $20.21 | $2.68 |
| Average True Range (ATR) | 1.47 | 0.26 |
| MACD | -0.59 | 0.04 |
| Stochastic Oscillator | 8.80 | 98.73 |
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.